FDA set to decide on first mRNA flu vaccine approval

The FDA is poised to decide whether to approve the first flu vaccine based on mRNA technology — the same platform used in COVID-19 shots. The decision comes amid the long-standing scepticism of Health Secretary Robert F. Kennedy Jr. towards mRNA vaccines. Approval would mark a milestone in flu prevention.